Condition: Breast Cancer Female · Sponsor: Maastricht University Medical Center
This multicentre randomized controlled trial aims to evaluate a new breast reconstruction technique- autologous fat transfer (AFT). Female patients with breast cancer schedule to receive a mastectomy (or having undergone mastectomy in the past) will be randomized to undergo breast reconstruction with either AFT with the EVEBRA device(intervention group) or AFT without the EVEBRA device (control group). AFT will be evaluated in terms of volume, quality of life, aesthetic result, complications and oncological safety.
This description comes directly from the study's public registry record.
Maud Rijkx, MD, MsC · +31 (0) 43 38 723 08 · maud.rijkx@mumc.nl
Always discuss trial participation with your own doctor first.
| Maastricht University Medical Center+ | Maastricht, Limburg, Netherlands | Recruiting |
| Amsterdam University Medical Center (VUMC) | Amsterdam, Netherlands | Recruiting |
| Ziekenhuis groep Twente (ZGT) | Hengelo, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05003635